| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Kinase Fusion Gene:AMBP_RPS6KB1 |
Kinase Fusion Protein Summary |
 Kinase Fusion gene summary |
| Kinase Fusion partner gene information | Kinase Fusion gene name: AMBP_RPS6KB1 | KinaseFusionDB ID: KFG342 | FusionGDB2.0 ID: KFG342 | Hgene | Tgene | Gene symbol | AMBP | RPS6KB1 | Gene ID | 259 | 6198 | |
| Gene name | alpha-1-microglobulin/bikunin precursor | ribosomal protein S6 kinase B1 | ||||||||||
| Synonyms | A1M|EDC1|HCP|HI30|IATIL|ITI|ITIL|ITILC|UTI | PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha | ||||||||||
| Cytomap | 9q32 | 17q23.1 | ||||||||||
| Type of gene | protein-coding | protein-coding | ||||||||||
| Description | protein AMBPbikunincomplex-forming glycoprotein heterogeneous in chargegrowth-inhibiting protein 19inter-alpha-trypsin inhibitor light chainprotein HCtrypstatinuristatinuronic-acid-rich protein | ribosomal protein S6 kinase beta-1ribosomal protein S6 kinase Iribosomal protein S6 kinase, 70kDa, polypeptide 1serine/threonine kinase 14 alphaserine/threonine-protein kinase 14A | ||||||||||
| Modification date | 20240330 | 20240411 | ||||||||||
| UniProtAcc | P02760 | P23443 | ||||||||||
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000265132, | ENST00000225577, ENST00000393021, ENST00000406116, ENST00000443572, ENST00000587061, | |||||||||
| Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: AMBP [Title/Abstract] AND RPS6KB1 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | AMBP(116822407)-RPS6KB1(57978987), # samples:1 | |||||||||||
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | RPS6KB1 | GO:0031667 | response to nutrient levels | 29750193 |
| Tgene | RPS6KB1 | GO:0031670 | cellular response to nutrient | 22017876 |
| Tgene | RPS6KB1 | GO:0031929 | TOR signaling | 12150926 |
| Tgene | RPS6KB1 | GO:0045948 | positive regulation of translational initiation | 1922062 |
| Tgene | RPS6KB1 | GO:0071363 | cellular response to growth factor stimulus | 17936702 |
| Tgene | RPS6KB1 | GO:1904263 | positive regulation of TORC1 signaling | 22017876 |
| Kinase Fusion gene breakpoints across AMBP (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Kinase Fusion gene breakpoints across RPS6KB1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
| Kinase Fusion gene information. |
| Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
| ChiTaRS5.0 | AV698075 | AMBP | chr9 | 116822407 | RPS6KB1 | chr17 | 57978987 |
Top |
Kinase Fusion ORF Analysis |
| Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:116822407/:57978987) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AMBP | RPS6KB1 |
| FUNCTION: [Alpha-1-microglobulin]: Antioxidant and tissue repair protein with reductase, heme-binding and radical-scavenging activities. Removes and protects against harmful oxidants and repairs macromolecules in intravascular and extravascular spaces and in intracellular compartments (PubMed:11877257, PubMed:15683711, PubMed:22096585, PubMed:23157686, PubMed:23642167, PubMed:25698971, PubMed:32823731, PubMed:32092412). Intravascularly, plays a regulatory role in red cell homeostasis by preventing heme- and reactive oxygen species-induced cell damage. Binds and degrades free heme to protect fetal and adult red blood cells from hemolysis (PubMed:11877257, PubMed:32092412). Reduces extracellular methemoglobin, a Fe3+ (ferric) form of hemoglobin that cannot bind oxygen, back to the Fe2+ (ferrous) form deoxyhemoglobin, which has oxygen-carrying potential (PubMed:15683711). Upon acute inflammation, inhibits oxidation of low-density lipoprotein particles by MPO and limits vascular damage (PubMed:25698971). Extravascularly, protects from oxidation products formed on extracellular matrix structures and cell membranes. Catalyzes the reduction of carbonyl groups on oxidized collagen fibers and preserves cellular and extracellular matrix ultrastructures (PubMed:23642167, PubMed:22096585). Importantly, counteracts the oxidative damage at blood-placenta interface, preventing leakage of free fetal hemoglobin into the maternal circulation (PubMed:21356557). Intracellularly, has a role in maintaining mitochondrial redox homeostasis. Bound to complex I of the respiratory chain of mitochondria, may scavenge free radicals and preserve mitochondrial ATP synthesis. Protects renal tubule epithelial cells from heme-induced oxidative damage to mitochondria (PubMed:23157686, PubMed:32823731). Reduces cytochrome c from Fe3+ (ferric) to the Fe2+ (ferrous) state through formation of superoxide anion radicals in the presence of ascorbate or NADH/NADPH electron donor cofactors, ascorbate being the preferred cofactor (PubMed:15683711). Has a chaperone role in facilitating the correct folding of bikunin in the endoplasmic reticulum compartment (By similarity). {ECO:0000250|UniProtKB:Q07456, ECO:0000269|PubMed:11877257, ECO:0000269|PubMed:15683711, ECO:0000269|PubMed:21356557, ECO:0000269|PubMed:22096585, ECO:0000269|PubMed:23157686, ECO:0000269|PubMed:23642167, ECO:0000269|PubMed:25698971, ECO:0000269|PubMed:32092412, ECO:0000269|PubMed:32823731}.; FUNCTION: [Inter-alpha-trypsin inhibitor light chain]: Kunitz-type serine protease inhibitor and structural component of extracellular matrix with a role in extracellular space remodeling and cell adhesion (PubMed:25301953, PubMed:20463016). Among others, has antiprotease activity toward kallikrein, a protease involved in airway inflammation; inhibits GZMK/granzyme, a granule-stored serine protease involved in NK and T cell cytotoxic responses; and inhibits PLG/plasmin, a protease required for activation of matrix metalloproteinases (PubMed:16873769, PubMed:10480954, PubMed:15917224). As part of I-alpha-I complex, provides for the heavy chains to be transferred from I-alpha-I complex to hyaluronan in the presence of TNFAIP6, in a dynamic process that releases free bikunin and remodels extracellular matrix proteoglycan structures. Free bikunin, but not its heavy chain-bound form, acts as potent protease inhibitor in airway secretions (PubMed:16873769). Part of hyaluronan-rich extracellular matrix that surrounds oocyte during cumulus oophorus expansion, an indispensable process for proper ovulation (By similarity). Also inhibits calcium oxalate crystallization (PubMed:7676539). {ECO:0000250|UniProtKB:Q07456, ECO:0000269|PubMed:10480954, ECO:0000269|PubMed:15917224, ECO:0000269|PubMed:16873769, ECO:0000269|PubMed:20463016, ECO:0000269|PubMed:25301953, ECO:0000269|PubMed:7676539}.; FUNCTION: [Trypstatin]: Kunitz-type serine protease inhibitor. Has high catalytic efficiency for F10/blood coagulation factor Xa and may act as an anticoagulant by inhibiting prothrombin activation. Inhibits trypsin and mast cell CMA1/chymase and tryptase proteases. {ECO:0000250|UniProtKB:Q64240}. | FUNCTION: Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:23429703, PubMed:28178239, PubMed:22017876). Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:23429703, PubMed:28178239, PubMed:22017876). Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex (PubMed:16286006). Upon mitogenic stimulation, phosphorylation by the mechanistic target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation (PubMed:16286006). The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B (PubMed:16286006). Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis (PubMed:17053147). Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR (PubMed:15341740). In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2 (PubMed:11500364). Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling (PubMed:19720745, PubMed:19935711, PubMed:19995915). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function (By similarity). Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex (PubMed:17936702). The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function (PubMed:17936702). Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1 (PubMed:18952604). In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B (PubMed:17052453). May be involved in cytoskeletal rearrangement through binding to neurabin (By similarity). Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR (PubMed:23429703). Following activation by mTORC1, phosphorylates EPRS and thereby plays a key role in fatty acid uptake by adipocytes and also most probably in interferon-gamma-induced translation inhibition (PubMed:28178239). {ECO:0000250|UniProtKB:P67999, ECO:0000250|UniProtKB:Q8BSK8, ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:12801526, ECO:0000269|PubMed:14673156, ECO:0000269|PubMed:15071500, ECO:0000269|PubMed:15341740, ECO:0000269|PubMed:16286006, ECO:0000269|PubMed:17052453, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:18952604, ECO:0000269|PubMed:19085255, ECO:0000269|PubMed:19720745, ECO:0000269|PubMed:19935711, ECO:0000269|PubMed:19995915, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:28178239}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
| - Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of AMBP_RPS6KB1 |
| Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
| Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
| RPS6KB1 | P23443 | human | BACH2 | Q9BYV9 | S521 | ETRTRTssSCSsYsY | |
| RPS6KB1 | P23443 | human | IRS1 | P35568 | S636 | sGDyMPMsPKsVSAP | |
| RPS6KB1 | P23443 | human | NDRG2 | Q9UN36 | S350 | RsRsRtLsQssEsGt | |
| RPS6KB1 | P23443 | human | KHSRP | Q92945 | S395 | DLLQSLrsGPPGPPG | |
| RPS6KB1 | P23443 | human | PDCD4 | Q53EL6 | S67 | kRRLRKNssRDsGrG | |
| RPS6KB1 | P23443 | human | TP63 | Q9H3D4 | S560 | LARLGCSsCLDYFTT | SAM_2 |
| RPS6KB1 | P23443 | human | MTOR | P42345 | S2448 | RsRtRtDsysAGQsV | |
| RPS6KB1 | P23443 | human | TRIB2 | Q92519 | S83 | FRAVHLHsGEELVCK | Pkinase |
| RPS6KB1 | P23443 | human | RPS6 | P62753 | S240 | RLssLRAstsKsEss | |
| RPS6KB1 | P23443 | human | RPS6KB1 | P23443 | T412 | NQVFLGFtyVAPsVL | Pkinase_C |
| RPS6KB1 | P23443 | human | SMN1 | Q16637 | S49 | AyDkAVAsFkHALkN | SMN |
| RPS6KB1 | P23443 | human | EEF2K | O00418 | S366 | sPQVRtLsGSRPPLL | |
| RPS6KB1 | P23443 | human | BACH2 | Q9BYV9 | S520 | LETRTRTssSCSsYs | |
| RPS6KB1 | P23443 | human | MXD1 | Q05195 | S145 | IERIRMDsIGSTVSS | |
| RPS6KB1 | P23443 | human | IRS1 | P35568 | S307 | TRRsRtEsItAtsPA | |
| RPS6KB1 | P23443 | human | URI1 | O94763 | S372 | AKRKRKNstGsGHsA | |
| RPS6KB1 | P23443 | human | MAPT | P10636-8 | S262 | NVKskIGstENLkHQ | Tubulin-binding |
| RPS6KB1 | P23443 | human | PDCD4 | Q53EL6 | S457 | RGRKRFVsEGDGGRL | |
| RPS6KB1 | P23443 | human | IRS1 | P35568 | S527 | RFRKRtHsAGtsPtI | |
| RPS6KB1 | P23443 | human | NCBP1 | Q09161 | S7 | _MSRRRHsDENDGGQ | |
| RPS6KB1 | P23443 | human | IRS1 | P35568 | S270 | EFRPRsKsQSssNCs | |
| RPS6KB1 | P23443 | human | H2BC3 | P33778 | S36 | RKRsRkEsysIyVyk | Histone |
| RPS6KB1 | P23443 | human | PIP5K1C | O60331 | T553 | QPRYRRRtQssGQDG | |
| RPS6KB1 | P23443 | human | POLDIP3 | Q9BY77 | S385 | PRRVNsAsSsNPPAE | |
| RPS6KB1 | P23443 | human | TARBP2 | Q15633 | S283 | ILSLRsCsLGsLGAL | |
| RPS6KB1 | P23443 | human | MTOR | P42345 | T2446 | NKRsRtRtDsysAGQ | |
| RPS6KB1 | P23443 | human | FMR1 | Q06787 | S500 | NSEASNAsETESDHR | FXMRP1_C_core |
| RPS6KB1 | P23443 | human | IRS1 | P35568 | S1101 | GCRRRHssEtFsStP | |
| RPS6KB1 | P23443 | human | RPS6 | P62753 | S244 | LRAstsKsEssQK__ | |
| RPS6KB1 | P23443 | human | GSK3B | P49841 | S9 | SGRPRttsFAEsCkP | |
| RPS6KB1 | P23443 | human | ZBTB33 | Q86T24 | T606 | yLSDRSStIPAMkDD | |
| RPS6KB1 | P23443 | human | NDRG2 | Q9UN36 | S332 | LsRsRtAsLtsAAsV | |
| RPS6KB1 | P23443 | human | MAPT | P10636-8 | S214 | GsRsRtPsLPtPPtR | |
| RPS6KB1 | P23443 | human | DEPTOR | Q8TB45 | S287 | sMssCGssGyFsssP | |
| RPS6KB1 | P23443 | human | ESR1 | P03372 | S167 | GGRERLAsTNDkGSM | Oest_recep |
| RPS6KB1 | P23443 | human | LTC4S | Q16873 | S36 | ARRAFRVsPPLtTGP | MAPEG |
| RPS6KB1 | P23443 | human | RPS6 | P62753 | S236 | AKRRRLssLRAstsK | |
| RPS6KB1 | P23443 | human | MRE11 | P49959 | T597 | sQrGrADtGLETSTr | |
| RPS6KB1 | P23443 | human | CAD | P27708 | S1859 | PPRIhRAsDPGLPAE | |
| RPS6KB1 | P23443 | human | NCBP1 | Q09161 | S22 | PHKRRKtsDANEtED | |
| RPS6KB1 | P23443 | human | DEPTOR | Q8TB45 | S286 | ssMssCGssGyFsss | |
| RPS6KB1 | P23443 | human | EGLN1 | Q9GZT9 | S125 | ADPAAAAsPCRAAAG | |
| RPS6KB1 | P23443 | human | CCT2 | P78371 | S260 | GsRVRVDstAkVAEI | Cpn60_TCP1 |
| RPS6KB1 | P23443 | human | MAPT | P10636-8 | T212 | tPGsRsRtPsLPtPP | |
| RPS6KB1 | P23443 | human | PIP5K1C | O60331 | S555 | RYRRRtQssGQDGRP | |
| RPS6KB1 | P23443 | human | GLI1 | P08151 | S84 | LTKKRALsISPLSDA | |
| RPS6KB1 | P23443 | human | MSH6 | P52701 | S309 | RMVtGNGsLKRKSSR | |
| RPS6KB1 | P23443 | human | RICTOR | Q6R327 | T1135 | NRRIRtLtEPsVDFN | RICTOR_phospho |
| RPS6KB1 | P23443 | human | SRPK2 | P78362 | S494 | HDRSRtVsAsstGDL | |
| RPS6KB1 | P23443 | human | NCBP1 | Q09161 | T21 | QPHKRRKtsDANEtE | |
| RPS6KB1 | P23443 | human | EIF4B | P23588 | S422 | RERsRtGsEssQtGt | |
| RPS6KB1 | P23443 | human | RPS6 | P62753 | S235 | IAKRRRLssLRAsts | |
| RPS6KB1 | P23443 | human | POLDIP3 | Q9BY77 | S383 | ELPRRVNsAsSsNPP | |
| RPS6KB1 | P23443 | human | DEPTOR | Q8TB45 | S291 | CGssGyFsssPtLss | |
| RPS6KB1 | P23443 | human | EPRS1 | P07814 | S999 | NQGGGLsssGAGEGQ | |
| RPS6KB1 | P23443 | human | CDK1 | P06493 | S39 | MkkIRLEsEEEGVPs | Pkinase |
| RPS6KB1 | P23443-2 | human | GSK3B | P49841 | S9 | SGRPRttsFAEsCkP | |
| RPS6KB1 | P23443-2 | human | EPRS1 | P07814 | S999 | NQGGGLsssGAGEGQ |
| Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
| Enriched GO biological processes of the phosphorylation target genes of the kinase |
| Kinase | GOID | GO term | P.adjust |
| RPS6KB1 | ID | Description | 0.00e+00 |
| RPS6KB1 | GO:0045927 | positive regulation of growth | 4.45e-04 |
| RPS6KB1 | GO:0006446 | regulation of translational initiation | 4.45e-04 |
| RPS6KB1 | GO:0032868 | response to insulin | 4.45e-04 |
| RPS6KB1 | GO:0032869 | cellular response to insulin stimulus | 9.65e-04 |
| RPS6KB1 | GO:0043086 | negative regulation of catalytic activity | 9.65e-04 |
| RPS6KB1 | GO:1900034 | regulation of cellular response to heat | 9.65e-04 |
| RPS6KB1 | GO:0006413 | translational initiation | 9.65e-04 |
| RPS6KB1 | GO:0051348 | negative regulation of transferase activity | 9.69e-04 |
| RPS6KB1 | GO:0045936 | negative regulation of phosphate metabolic process | 1.25e-03 |
| RPS6KB1 | GO:0010563 | negative regulation of phosphorus metabolic process | 1.25e-03 |
| RPS6KB1 | GO:0043434 | response to peptide hormone | 2.49e-03 |
| RPS6KB1 | GO:0031929 | TOR signaling | 2.49e-03 |
| RPS6KB1 | GO:0018105 | peptidyl-serine phosphorylation | 2.79e-03 |
| RPS6KB1 | GO:0018209 | peptidyl-serine modification | 3.19e-03 |
| RPS6KB1 | GO:0071375 | cellular response to peptide hormone stimulus | 3.19e-03 |
| RPS6KB1 | GO:0033673 | negative regulation of kinase activity | 3.47e-03 |
| RPS6KB1 | GO:0006403 | RNA localization | 3.47e-03 |
| RPS6KB1 | GO:0006913 | nucleocytoplasmic transport | 3.47e-03 |
| RPS6KB1 | GO:0051169 | nuclear transport | 3.47e-03 |
| RPS6KB1 | GO:0046777 | protein autophosphorylation | 3.47e-03 |
| RPS6KB1 | GO:1901653 | cellular response to peptide | 6.48e-03 |
| RPS6KB1 | GO:0051028 | mRNA transport | 8.35e-03 |
| RPS6KB1 | GO:0033002 | muscle cell proliferation | 8.39e-03 |
| RPS6KB1 | GO:0030850 | prostate gland development | 8.98e-03 |
| RPS6KB1 | GO:0001558 | regulation of cell growth | 9.68e-03 |
| RPS6KB1 | GO:0043467 | regulation of generation of precursor metabolites and energy | 9.68e-03 |
| RPS6KB1 | GO:0045727 | positive regulation of translation | 9.68e-03 |
| RPS6KB1 | GO:0060525 | prostate glandular acinus development | 9.68e-03 |
| RPS6KB1 | GO:1905214 | regulation of RNA binding | 9.68e-03 |
| RPS6KB1 | GO:1900180 | regulation of protein localization to nucleus | 9.68e-03 |
| RPS6KB1 | GO:0031400 | negative regulation of protein modification process | 1.03e-02 |
| RPS6KB1 | GO:0010921 | regulation of phosphatase activity | 1.20e-02 |
| RPS6KB1 | GO:0002181 | cytoplasmic translation | 1.20e-02 |
| RPS6KB1 | GO:0050657 | nucleic acid transport | 1.20e-02 |
| RPS6KB1 | GO:0050658 | RNA transport | 1.20e-02 |
| RPS6KB1 | GO:0031100 | animal organ regeneration | 1.20e-02 |
| RPS6KB1 | GO:0048524 | positive regulation of viral process | 1.20e-02 |
| RPS6KB1 | GO:0051236 | establishment of RNA localization | 1.20e-02 |
| RPS6KB1 | GO:0030307 | positive regulation of cell growth | 1.23e-02 |
| RPS6KB1 | GO:0034605 | cellular response to heat | 1.23e-02 |
| RPS6KB1 | GO:0001655 | urogenital system development | 1.23e-02 |
| RPS6KB1 | GO:0048639 | positive regulation of developmental growth | 1.23e-02 |
| RPS6KB1 | GO:0051168 | nuclear export | 1.23e-02 |
| RPS6KB1 | GO:0034250 | positive regulation of amide metabolic process | 1.23e-02 |
| RPS6KB1 | GO:0038203 | TORC2 signaling | 1.23e-02 |
| RPS6KB1 | GO:1900452 | regulation of long-term synaptic depression | 1.23e-02 |
| RPS6KB1 | GO:0006406 | mRNA export from nucleus | 1.25e-02 |
| RPS6KB1 | GO:0016049 | cell growth | 1.28e-02 |
| RPS6KB1 | GO:0043201 | response to leucine | 1.28e-02 |
Top |
Related Drugs to AMBP_RPS6KB1 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
| Distribution of the number of studies mentioning AMBP-RPS6KB1 and kinase inhibitors the PubMed Abstract (04-01-2024) |
| Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to AMBP_RPS6KB1 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
| MeSH ID | MeSH term |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
| Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
| Clinical Trials from clinicaltrials.gov (06-17-2024) |
| Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |
Copyright 2024-Present -The University of Texas Health Science Center at Houston
Web File Viewing | Emergency Information |Campus Carry|Site Policies |